Solas BioVentures Overview
- Investor Type
- Venture Capital
- Status
- Active
- Professionals
- 4
- Investments
- 32
- Portfolio
- 21
- Exits
- 8
Solas BioVentures General Information
Description
Founded in 2014, Solas BioVentures is a venture capital firm based in Chattanooga, Tennessee. the firm seeks to invest in the life science industry, focusing primarily on early and development stage biopharma, medtech and digital health companies.
Contact Information
Website
www.solasbio.com
Year Founded
2014
Investor Status
Actively Seeking New Investments
Primary Investor Type
Venture Capital
Primary Office
- 412 Georgia Avenue
- Suite 201
- Chattanooga, TN 37402
- United States
Solas BioVentures Investments (32)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Company Stage | Lead Partner |
|---|---|---|---|---|---|---|
| Intershunt Technologies | 04-Jan-2021 | Later Stage VC | 00.000 | Therapeutic Devices | Generating Revenue | |
| 0000000 | 21-Dec-2020 | 00000 00000 | 000 | Surgical Devices | Generating Revenue | |
| 00 00000000 | 20-Nov-2020 | 00000 00000 | 0000 | Decision/Risk Analysis | Generating Revenue | |
| 00000 00000000000 | 11-Nov-2020 | 00000 00000 | 000.00 | Drug Discovery | Clinical Trials - Phase 2 | |
| 000000 00000000000 | 08-Oct-2020 | 00000 00000 | Drug Discovery | Clinical Trials - Phase 1 | ||
| 000000000 0000000 | 21-Feb-2020 | 00000 00000 | 000 | Surgical Devices | Generating Revenue | |
| 000000 | 13-Feb-2020 | 00000 00000 | 00.000 | Therapeutic Devices | Clinical Trials - Phase 1 | |
| 0000000000 | 14-Jan-2020 | 00000 00000 | 00.00 | Other Healthcare Technology Systems | Generating Revenue | |
| Stimdia Medical | 18-Dec-2019 | Early Stage VC | 00.00 | Therapeutic Devices | Pre-Clinical Trials | |
| Elira | 14-Nov-2019 | Early Stage VC | 00.000 | Therapeutic Devices | Startup |
Solas BioVentures Exits (8)
| Company Name | Exit Date | Exit Type | Exit Size |
|---|---|---|---|
| Mara(Other Devices and Supplies) | 02-Feb-2021 | Merger/Acquisition | |
| 000000000 0000000 | 15-Jan-2019 | 000 00 00000000 | |
| 0000000 | 21-Mar-2018 | 000000000000000000 | 00000 |
| 000000 0000000 | 01-Aug-2016 | 000000000000000000 | 0000 |
| 00000000 | 21-Dec-2012 | 000000000000000000 | 000.00 |
| 000000 000000000 | 000000000000000000 | ||
| Midnight Pharma | Secondary Transaction - Private | ||
| Veran Medical Technologies | Merger/Acquisition |
Solas BioVentures Investments by Industry, Year, and Region
Investments by Industry
Investments by Year
Investments by Region
PitchBook’s data visualizations quickly surface an investor’s historical investments—showing a breakdown of activity by industry, year and region.
Request a free trialSolas BioVentures Team (5)
| Name | Title | Deals | Funds | Boards | Office |
|---|---|---|---|---|---|
| Mark Hackett JD | Co-Founder & Managing Director | Chattanooga, TN | |||
| Casey Hammontree | Co-Founder & General Partner | Chattanooga, TN | |||
| Michael Hoey Ph.D | General Partner | Chattanooga, TN | |||
| Scott Rader | Partner & Senior Vice President | Chattanooga, TN | |||
| Joshua Eckelberry | Associate | Chattanooga, TN |
Solas BioVentures Co-Investors (31)
| Name | With | Exits | Lead Partner | Series | Industry |
|---|---|---|---|---|---|
| Perceptive Advisors | 2 | 0 | 0 |
|
|
| Santé | 0 | 0 |
|
|
|
| Alloy Ventures | 0 | 0 | 0 |
|
|
| Arboretum Ventures | 0 | 0 |
|
|
|
| Ascension Ventures | 0 | 0 |
|
|